Taisho Pharmaceutical (OTCMKTS:TAIPY) Now Covered by Jefferies Financial Group

Stock analysts at Jefferies Financial Group initiated coverage on shares of Taisho Pharmaceutical (OTCMKTS:TAIPY) in a research note issued on Monday, The Fly reports. The brokerage set a “hold” rating on the stock.

Taisho Pharmaceutical stock opened at $18.90 on Monday. Taisho Pharmaceutical has a 12 month low of $16.75 and a 12 month high of $28.52.

Taisho Pharmaceutical Company Profile

Taisho Pharmaceutical Holdings Co, Ltd., through its subsidiaries, researches, develops, manufactures, and sells over-the-counter (OTC) drugs and prescription pharmaceuticals in Japan and internationally. It operates in two segments, Self-Medication Operation Group and Prescription Pharmaceutical Operation Group.

Recommended Story: What is the Dividend Aristocrat Index?

The Fly

Receive News & Ratings for Taisho Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taisho Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.